Free Trial
LON:HEMO

Hemogenyx Pharmaceuticals (HEMO) Share Price, News & Analysis

Hemogenyx Pharmaceuticals logo
GBX 144.22 -0.78 (-0.53%)
As of 07:53 AM Eastern

About Hemogenyx Pharmaceuticals Stock (LON:HEMO)

Key Stats

Today's Range
137.28
152
50-Day Range
145.96
186.81
52-Week Range
137.28
1,200
Volume
33,566 shs
Average Volume
31,295 shs
Market Capitalization
£5.14 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive HEMO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hemogenyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

HEMO Stock News Headlines

5 Stocks That Could Double Your Investment in 2025
5 Stocks That Could Double in 2025 🚀 Our analysts have identified five stocks with the potential to double in 2025. From a company poised to lead the crypto ETF market to an innovator in fuel cell technology for AI and data centers, these picks could be game-changers for your portfolio.
Hemogenyx Pharmaceuticals Announces Key Corporate Changes
See More Headlines

HEMO Stock Analysis - Frequently Asked Questions

Hemogenyx Pharmaceuticals' stock was trading at GBX 402 at the beginning of the year. Since then, HEMO stock has decreased by 64.7% and is now trading at GBX 141.88.

Hemogenyx Pharmaceuticals Plc (LON:HEMO) posted its quarterly earnings data on Monday, April, 28th. The company reported ($181.10) earnings per share for the quarter.

Shares of HEMO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Hemogenyx Pharmaceuticals investors own include 4D pharma (DDDD), genedrive (GDR), International Consolidated Airlines Group (IAG), Active Energy Group (AEG), B&M European Value Retail (BME), BP (BP) and Coats Group (COA).

Company Calendar

Last Earnings
4/28/2025
Today
7/11/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:HEMO
Previous Symbol
LON:SILF
CIK
N/A
Fax
N/A
Employees
14
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (0.20)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£6.89 thousand
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-80.66%
Return on Assets
-37.79%

Debt

Debt-to-Equity Ratio
90.87
Current Ratio
4.38
Quick Ratio
6.72

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
GBX 70.53 per share
Price / Cash Flow
2.05
Book Value
GBX 0.25 per share
Price / Book
585.43

Miscellaneous

Outstanding Shares
3,564,489
Free Float
N/A
Market Cap
£5.14 million
Optionable
Not Optionable
Beta
3.14
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (LON:HEMO) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners